Krishnaswamy Yeleswaram
Chief Development Officer · Rapport Therapeutics, Inc.
- 2026
- Aug 26, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Krishnaswamy Yeleswaram files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Third Rock Ventures V, L.P. - $34.39M in RAPP purchases and sales in the last 12 months
- Abraham Ceesay - $5.93M in RAPP purchases and sales in the last 12 months
- Cheryl Gault - $1.24M in RAPP purchases and sales in the last 12 months
- David Bredt - $1.14M in RAPP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Krishnaswamy Yeleswaram?
Krishnaswamy Yeleswaram is a corporate insider, tracked as Chief Development Officer of Rapport Therapeutics, Inc. (RAPP). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Krishnaswamy Yeleswaram submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Krishnaswamy Yeleswaram been buying or selling stock?
Recorded transactions: 0 open-market purchases and 11 open-market sales ($4.46M) across all tracked filings.
